The bovine insulin-like growth factor (IGF) binding protein purified from conditioned medium requires the N-terminal tripeptide in IGF-1 for binding.
about
Altered affinity of insulin-like growth factor II (IGF-II) for receptors and IGF-binding proteins, resulting from limited modifications of the IGF-II moleculeInsulin-like growth factor 1 physiology: lessons from mouse models.Isolation of an inhibitory insulin-like growth factor (IGF) binding protein from bone cell-conditioned medium: a potential local regulator of IGF action.Estrogen-IGF-1 interactions in neuroprotection: ischemic stroke as a case study.Unbound (bioavailable) IGF1 enhances somatic growth.Insulin-like growth factor I expression by tumors of neuroectodermal origin with the t(11;22) chromosomal translocation. A potential autocrine growth factorInsulin-like growth factor binding proteins: structural and molecular relationships.Insulin-like growth factor binding protein-2 mediates the inhibition of DNA synthesis by transforming growth factor-beta in mink lung epithelial cells.Insulin-like growth factor (IGF)-binding proteins inhibit the biological activities of IGF-1 and IGF-2 but not des-(1-3)-IGF-1.Spatial polarization of insulin-like growth factor receptors on the human syncytiotrophoblast.Insulin-like growth factor (IGF)-II binding to IGF-binding proteins and IGF receptors is modified by deletion of the N-terminal hexapeptide or substitution of arginine for glutamate-6 in IGF-II.Mutations in the B-domain of insulin-like growth factor-I influence the oxidative folding to yield products with modified biological propertiesA key functional role for the insulin-like growth factor 1 N-terminal pentapeptide.Alanine screening mutagenesis establishes tyrosine 60 of bovine insulin-like growth factor binding protein-2 as a determinant of insulin-like growth factor binding.Cloning and characterization of a cDNA encoding the bovine insulin-like growth factor binding protein 1 (bIGFBP-1).Insulin-like growth factor (IGF)-I binding to a cell membrane associated IGF binding protein-3 acid-labile subunit complex in human anterior pituitary gland.Biosensor measurement of the binding of insulin-like growth factors I and II and their analogues to the insulin-like growth factor-binding protein-3.The Insulin-like Growth Factor (IGF) Binding Site of Bovine Insulin-like Growth Factor Binding Protein-2 (bIGFBP-2) Probed by Iodination
P2860
Q28324041-77219B94-080B-49C7-A0CE-6313366A63D5Q33846069-7E429751-B6E3-41F8-B137-54F7CAE76C37Q34315552-98183202-BC20-4C6B-9458-4B29C229F8C5Q34587752-D01A67D9-C1EF-4241-84C5-A65B9F8D1EDBQ35232634-C2225FEA-7B38-46F6-A032-909FE926E257Q35816926-25CE87A7-25BE-4B93-9C7C-AB660F8A987AQ36710585-23B939E3-CB5A-409C-B33C-2E73DF8692FCQ40755306-4C689535-3A03-439F-B956-495EF5906246Q41848926-86EE25AF-EE89-4B23-90D0-C2A0A33C2191Q42529089-25D2D779-CE4E-4597-BB07-B6105CD29418Q42811185-6CD5C1FD-491B-4CE3-9DAB-E6DF466DF2CBQ42826197-637291BE-9E50-48F9-B77E-D395C6042CB1Q42836096-C4B2B1B1-F470-4939-A209-871E04128020Q47792080-B603C0B0-A0C5-4CD9-9403-C17307D277B2Q48242346-129E59DB-4D99-4210-8DEC-6C5E68622A25Q48544279-9CCE0FC8-ACAA-40B7-BFB4-81840066C033Q52303276-50ECDC3D-90B8-4873-843C-F2A9FBDF837AQ58024207-5D56A164-8EBC-4486-97B1-3E8F00477F08
P2860
The bovine insulin-like growth factor (IGF) binding protein purified from conditioned medium requires the N-terminal tripeptide in IGF-1 for binding.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh-hant
name
The bovine insulin-like growth ...... ipeptide in IGF-1 for binding.
@en
The bovine insulin-like growth factor
@nl
type
label
The bovine insulin-like growth ...... ipeptide in IGF-1 for binding.
@en
The bovine insulin-like growth factor
@nl
prefLabel
The bovine insulin-like growth ...... ipeptide in IGF-1 for binding.
@en
The bovine insulin-like growth factor
@nl
P2093
P1476
The bovine insulin-like growth ...... ipeptide in IGF-1 for binding.
@en
P2093
Ballard FJ
Mottershead DG
Wallace JC
P304
P356
10.1016/0006-291X(88)90580-3
P407
P577
1988-02-01T00:00:00Z